Koola MM

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (7)

Title : Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond - Koola_2020_Psychiatry.Res_293_113409
Author(s) : Koola MM
Ref : Psychiatry Res , 293 :113409 , 2020
Abstract : Koola_2020_Psychiatry.Res_293_113409
ESTHER : Koola_2020_Psychiatry.Res_293_113409
PubMedSearch : Koola_2020_Psychiatry.Res_293_113409
PubMedID: 32829072

Title : Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement - Koola_2020_Psychiatry.Res_291_113285
Author(s) : Koola MM , Looney SW , Hong H , Pillai A , Hou W
Ref : Psychiatry Res , 291 :113285 , 2020
Abstract : Koola_2020_Psychiatry.Res_291_113285
ESTHER : Koola_2020_Psychiatry.Res_291_113285
PubMedSearch : Koola_2020_Psychiatry.Res_291_113285
PubMedID: 32763546

Title : Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis? - Koola_2018_Mol.Neuropsychiatry_4_71
Author(s) : Koola MM
Ref : Mol Neuropsychiatry , 4 :71 , 2018
Abstract : Koola_2018_Mol.Neuropsychiatry_4_71
ESTHER : Koola_2018_Mol.Neuropsychiatry_4_71
PubMedSearch : Koola_2018_Mol.Neuropsychiatry_4_71
PubMedID: 30397594

Title : Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target Engagement - Koola_2018_Prim.Care.Companion.CNS.Disord_20_
Author(s) : Koola MM
Ref : Prim Care Companion CNS Disord , 20 : , 2018
Abstract : Koola_2018_Prim.Care.Companion.CNS.Disord_20_
ESTHER : Koola_2018_Prim.Care.Companion.CNS.Disord_20_
PubMedSearch : Koola_2018_Prim.Care.Companion.CNS.Disord_20_
PubMedID: 29570959

Title : Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia - Koola_2018_Mol.Neuropsychiatry_4_134
Author(s) : Koola MM
Ref : Mol Neuropsychiatry , 4 :134 , 2018
Abstract : Koola_2018_Mol.Neuropsychiatry_4_134
ESTHER : Koola_2018_Mol.Neuropsychiatry_4_134
PubMedSearch : Koola_2018_Mol.Neuropsychiatry_4_134
PubMedID: 30643787

Title : Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine - Koola_2016_Schizophr.Res.Cogn_4_4
Author(s) : Koola MM
Ref : Schizophr Res Cogn , 4 :4 , 2016
Abstract : Koola_2016_Schizophr.Res.Cogn_4_4
ESTHER : Koola_2016_Schizophr.Res.Cogn_4_4
PubMedSearch : Koola_2016_Schizophr.Res.Cogn_4_4
PubMedID: 27069875

Title : Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia - Koola_2014_Schizophr.Res_157_84
Author(s) : Koola MM , Buchanan RW , Pillai A , Aitchison KJ , Weinberger DR , Aaronson ST , Dickerson FB
Ref : Schizophr Res , 157 :84 , 2014
Abstract : Koola_2014_Schizophr.Res_157_84
ESTHER : Koola_2014_Schizophr.Res_157_84
PubMedSearch : Koola_2014_Schizophr.Res_157_84
PubMedID: 24878431